James M. Thorburn

Former Chief Financial OfficeratTwist Bioscience· In proxies 2021–2024

Pay in FY2024-39% from the year before · Twist Bioscience stock +123.0% the same year

James M. Thorburn was paid $1.1M in FY2024 (Sep), down 39%. Twist Bioscience stock rose 123.0% that year.

Pay$100 in the stock at the end of FY20 → $59

Pay is from the Summary Compensation Table of each Twist Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Twist BiosciencePublic company · 5 yr
- Former Chief Financial Officer2021 – Present · 5 yrStock in role +168%

Roles come from the proxy statements of each company.

Activity

Pay
Twist Bioscience Former CFO pay fell 39% to $1.1M. The stock rose 123% in FY2024 (Sep).
DEF 14AJan 6, 2025
Pay
Twist Bioscience Former CFO pay rose 251% to $2.7M. The stock fell 67% in FY2022 (Sep).
DEF 14AJan 6, 2025
Pay
Twist Bioscience Former CFO pay fell 33% to $1.8M. The stock fell 43% in FY2023 (Sep).
DEF 14AJan 5, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?